Molecule Details
| InChIKey | OGJPXUAPXNRGGI-UHFFFAOYSA-N |
|---|---|
| Compound Name | Norfloxacin |
| Canonical SMILES | CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.15 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB01059 |
|---|---|
| Drug Name | Norfloxacin |
| CAS Number | 70458-96-7 |
| Groups | approved investigational |
| ATC Codes | J01RA14 J01RA13 S01AE02 J01MA06 |
| Description | A synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA gyrase. |
Categories: 4-Quinolones Agents Causing Muscle Toxicity Anti-Bacterial Agents Anti-Infective Agents Antibacterials for Systemic Use Antiinfectives for Systemic Use Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A7 Inhibitors Cytochrome P-450 CYP3A7 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors Fluoroquinolones Heterocyclic Compounds, Fused-Ring OAT1/SLC22A6 inhibitors Ophthalmologicals Potential QTc-Prolonging Agents QTc Prolonging Agents Quinolines Quinolone Antimicrobial Quinolones Sensory Organs Topoisomerase II Inhibitors Topoisomerase Inhibitors
Cross-references: BindingDB: 50045000 ChEBI: 100246 CHEMBL9 ChemSpider: 4380 Drugs Product Database (DPD): 1838 C06687 D00210 PharmGKB: PA450654 PubChem:4539 PubChem:46508634 RxCUI: 7517 Therapeutic Targets Database: DAP000654 Wikipedia: Norfloxacin ZINC: ZINC000000003742
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O60885 | BRD4 | Homo sapiens | Human | PF17035 PF17105 PF00439 | 6.0 | IC50 | ChEMBL |
| P0AES4 | gyrA | Escherichia coli (strain K12) | Pathogen | PF03989 PF00521 | 6.2 | IC50 | ChEMBL;BindingDB |
| P0AES6 | gyrB | Escherichia coli (strain K12) | Pathogen | PF00204 PF00986 PF21249 PF18053 PF02518 PF01751 | 6.2 | IC50 | ChEMBL |
DrugBank Target Actions (12)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P04798 | CYP1A1 | Cytochrome P450 1A1 | inhibitor | enzymes |
| P05177 | CYP1A2 | Cytochrome P450 1A2 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P24462 | CYP3A7 | Cytochrome P450 3A7 | inhibitor | enzymes |
| P0C1U9 | parC | DNA topoisomerase 4 subunit A | inhibitor | targets |
| P11388 | TOP2A | DNA topoisomerase 2-alpha | inhibitor | targets |
| P20831 | gyrA | DNA gyrase subunit A | inhibitor | targets |
| P43700 | P43700 | DNA gyrase subunit A | inhibitor | targets |
| P43702 | P43702 | DNA topoisomerase 4 subunit A | inhibitor | targets |
| P0A0K8 | gyrB | DNA gyrase subunit B | modulator | targets |
| O76082 | O76082 | Organic cation/carnitine transporter 2 | inhibitor | transporters |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 | inhibitor | transporters |